Ledger.Open graph →
SEC Form D · Amendment · filed March 29, 2021

Gemelli Biotech Corp

Offering
$5.5M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Matthew Mitcho · Los Angeles, CAExec · DirectorJames Laur · Los Angeles, CADirectorMark Pimentel · Los Angeles, CAExec · DirectorVincent P. Easi · OTTAWA, ILDirectorWilliam K. Walsh · OTTAWA, ILExec · DirectorSteven M. Gonzalo · OTTAWA, ILExec · DirectorKyle N. Tompane · El Cajon, CAExec · DirectorGarrett T. Moore · El Cajon, CAExec · DirectorCharles Crain · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗